Hancock W W, Kraft N, Clarke F, Atkins R C
Pathology. 1984 Apr;16(2):197-206. doi: 10.3109/00313028409059105.
A series of monoclonal antibodies to human glomerular antigens was prepared by immunisation of a mouse with isolated whole glomeruli, followed by boosting with particulate glomerular basement membrane and fusion of murine spleen cells with the NSI-myeloma line. Hybridoma supernatants were screened jointly by a radioimmunoassay involving binding to isolated glomeruli, and by a 4-layer immunoperoxidase technique applied to polyester wax-embedded sections. Seven monoclonal antibodies with different specificities (PHM7-PHM13) were established and repeatedly cloned. Each antibody displayed a distinctive distribution within the glomerulus, including different patterns of staining of mesangial cells, mesangial matrix and glomerular basement membrane, in addition to extra-glomerular basement membranes and extracellular matrix. All antibodies also stained cellular outgrowths of isolated glomeruli cultured in vitro, and showed additive binding to cultured cells by radioimmunoassay. Physical characterization using absorptions with purified substrates, plus specific chemical and enzymatic digestions, indicated that PHM12 is directed against type IV collagen. PHM13 is directed against fibronectin as shown by absorption with purified fibronectin and immunoprecipitation of a 220 000 MW glycoprotein. The remaining 5 monoclonal antibodies, which react with carbohydrate (PHM7) or protein (PHM8-PHM11) determinants, were shown to be nonreactive with type IV collagen, fibronectin or other known glomerular components including sialic acid, laminin, amyloid P-component or various glycosaminoglycans. These monoclonal antibodies therefore appear to define a new series of human glomerular antigens, or possibly closely related antigenic determinants, which are synthesized by glomerular cells and incorporated into the mesangium and glomerular basement membrane. These antibodies, by providing markers for at least 2 antigens known to be important in glomerular cell-matrix interactions, should prove useful in research into the mechanisms involved in renal pathology.
用分离出的完整肾小球免疫小鼠,随后用颗粒状肾小球基底膜加强免疫,并将鼠脾细胞与NSI骨髓瘤细胞系融合,制备了一系列针对人肾小球抗原的单克隆抗体。通过涉及与分离出的肾小球结合的放射免疫测定法,以及应用于聚酯蜡包埋切片的四层免疫过氧化物酶技术,联合筛选杂交瘤细胞培养上清液。建立了7种具有不同特异性的单克隆抗体(PHM7 - PHM13)并反复克隆。每种抗体在肾小球内均呈现独特的分布,包括系膜细胞、系膜基质和肾小球基底膜不同的染色模式,此外还包括肾小球外基底膜和细胞外基质。所有抗体还对体外培养的分离肾小球的细胞生长进行染色,并通过放射免疫测定法显示与培养细胞有加成结合。使用纯化底物吸收以及特定化学和酶消化进行的物理特性鉴定表明,PHM12针对IV型胶原。通过与纯化的纤连蛋白吸收以及对220 000 MW糖蛋白的免疫沉淀表明,PHM13针对纤连蛋白。其余5种与碳水化合物(PHM7)或蛋白质(PHM8 - PHM11)决定簇反应的单克隆抗体,被证明与IV型胶原、纤连蛋白或其他已知的肾小球成分(包括唾液酸、层粘连蛋白、淀粉样P成分或各种糖胺聚糖)无反应。因此,这些单克隆抗体似乎定义了一系列新的人肾小球抗原,或可能是密切相关的抗原决定簇,它们由肾小球细胞合成并整合到系膜和肾小球基底膜中。这些抗体通过为至少2种已知在肾小球细胞 - 基质相互作用中起重要作用的抗原提供标记,应在肾脏病理学相关机制的研究中证明是有用的。